Inhibition of Endogenous Ganglioside Synthesis Does Not Block Neurite Formation by Retinoic Acid-treated Neuroblastoma Cells*

(Received for publication, April 3, 1996, and in revised form, September 27, 1996)

Ruixiang Li and Stephan Ladisch Dagger

From the Glycobiology Program, Center for Cancer and Transplantation Biology, Children's Research Institute, and Departments of Pediatrics and Biochemistry/Molecular Biology, George Washington University School of Medicine, Washington, D. C. 20010

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

Gangliosides are believed to play a critical role in cellular differentiation. To test this concept, we determined the effect of inhibition of endogenous ganglioside synthesis upon neurite formation induced by retinoic acid in LAN-5 human neuroblastoma cells. Ganglioside synthesis and content of LAN-5 cells exposed for 6 days to 10 µM D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) (an inhibitor of glucosylceramide synthase) were reduced by >90%. However, these ganglioside-depleted cells were not blocked from forming neurites when exposed to 10 µM retinoic acid. Even more extensive treatment of LAN-5 cells with 20 µM D-PDMP (6 day pretreatment followed by 6 days together with 10 µM retinoic acid) still did not block the retinoic acid-induced neurite formation. An element of neuroblastoma tumor cell differentiation, neurite formation, is therefore dependent neither on an intact cellular ganglioside complement nor on new ganglioside synthesis.


INTRODUCTION

The high concentrations of gangliosides in the central nervous system have led to the widely held view that these molecules may play an important role in the differentiation of neuronal cells (1). There is evidence supporting this view, in that striking changes in ganglioside metabolism have been observed during both spontaneous and induced cellular differentiation (2, 3, 4). The treatment of LAN-5 human neuroblastoma cells with retinoic acid, which causes differentiation of the cells (5, 6), results in a marked increase in cellular ganglioside content (7). An increase in concentration of specific gangliosides (8), a switch in ganglioside biosynthetic pathways and the appearance of new gangliosides (9, 10), and changes in cellular ganglioside patterns (11) are generally considered to be important in the process of cellular differentiation, particularly in neuronal or neuroblastoma cells. Exogenous gangliosides also influence differentiation (12, 13, 14). However, the question of whether endogenous gangliosides are essential for cellular differentiation under physiological conditions remains to be answered.

To determine whether endogenous gangliosides are essential for the process of cellular differentiation, we developed the following strategy. In a model system, the LAN-5 human neuroblastoma cell line, which can be induced by retinoic acid to differentiate and form neurites (5, 6), we studied the effect of cellular ganglioside depletion upon neurite formation. D-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP),1 a potent inhibitor of glucosylceramide synthase (15, 16), was used to maximally inhibit ganglioside synthesis and deplete cellular ganglioside content. In this situation, despite down-regulation of cellular ganglioside synthesis and content of LAN-5 cells, the formation of neurites induced by exposure of these cells to retinoic acid was not blocked.


MATERIALS AND METHODS

Preparation of Retinoic Acid, D-PDMP, and Nerve Growth Factor Stock Solutions

Retinoic acid (all-trans form; Sigma) was dissolved in ethanol to a concentration of 10-2 M and kept as stock solution. For each experiment, retinoic acid was diluted from the stock solution directly into the growth medium. The final concentration of ethanol in the culture medium was <= 0.2% (v/v). D-PDMP was dissolved in distilled water at a concentration of 4 mM (15) and stored at 4 °C. This stock solution was directly added to culture medium (<= 0.5%, v/v) in each experiment. Nerve growth factor (human, recombinant NGF-beta , Sigma) was dissolved in phosphate-buffered saline with 0.1% bovine serum albumin. This stock solution was filtered and stored at -70 °C.

Cell Culture

LAN-5 human neuroblastoma cells were a generous gift from Dr. Robert Seeger. These cells (passages 94-98) were cultured as adherent monolayers in 75-cm2 flasks in Waymouth's MB 752/1 medium supplemented with 2 mM L-glutamine (Life Technologies, Inc., Grand Island, NY) and 10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT). Cell viability was assessed by trypan blue dye exclusion.

Induction of LAN-5 Cellular Differentiation

LAN-5 cells were treated with 10 µM all-trans-retinoic acid to induce cellular differentiation, which was judged by assessing neurite formation, cell proliferation (5, 6), and specific acetylcholinesterase activity (17). Neurite formation was observed and photographed under phase-contrast microscopy. Cells cultured in medium containing 0.2% ethanol were used as the control. Nerve growth factor (250-1000 ng/ml) was also used to induce neurite formation in LAN-5 cells.

Study of Ganglioside Biosynthesis by Metabolic Radiolabeling

LAN-5 cells were cultured in the presence or absence of D-PDMP for 72 h. D-[6-3H]Galactose (specific activity, 5 Ci/mmol) and D-[6-3H]glucosamine hydrocholoride (specific activity, 30.9 Ci/mmol, DuPont NEN, Boston, MA) were added to the culture medium (1 µCi ml-1) during the last 24 h. These radiolabeled cells were washed 3 times and harvested by trypsinization. The resulting cell suspension was centrifuged at 300 × g for 10 min, and the cell pellet was washed once with phosphate-buffered saline prior to processing for ganglioside purification (7, 18).

Ganglioside Purification and Analysis

The total lipids of the cells were isolated by chloroform/methanol extraction. Gangliosides were purified by diisopropyl ether/1-butanol partition (19) followed by Sephadex G-50 gel filtration. The purified gangliosides were quantified as nanomole of lipid-bound sialic acid (LBSA) by the modified resorcinol method (20), and ganglioside-associated radioactivity was quantified by beta -scintillation counting (Betafluor, National Diagnostics, Manville, NJ).


RESULTS

Regulation of Cellular Gangliosides by Retinoic Acid and D-PDMP

LAN-5 human neuroblastoma cells contain GD2 (56%), GM2 (15%), and GT1b (11%) as the main ganglioside components. The minor ganglioside species also seen are GM1, GD3, and GD1b (18). To provide the basis for studying the influence of endogenous gangliosides on cellular differentiation in this model system, we first established the effects of each agent on ganglioside synthesis and content. Retinoic acid, which induces differentiation, caused an increase in cellular ganglioside content. When LAN-5 cells were treated with 20 µM retinoic acid for 6 days, the cellular ganglioside content increased from 3.95 ± 0.39 (control) to 6.1 ± 0.13 nmol of LBSA/mg of protein (Fig. 1). In contrast, D-PDMP (which blocks ganglioside synthesis) caused depletion of cellular gangliosides. Exposure of LAN-5 cells to 20 µM D-PDMP for 6 days reduced cellular ganglioside content by 90%, to 0.41 ± 0.29 nmol of LBSA/mg of protein (Fig. 1). Moreover, as shown in Fig. 2, the inhibition of endogenous ganglioside content caused by D-PDMP was rapid and time-dependent; when LAN-5 cells were cultured in medium containing 10 µM D-PDMP, the cellular ganglioside content decreased rapidly, with a 42% reduction in cellular ganglioside content observed after 1 day. By day 6, the total cellular ganglioside content was reduced by 92%, to 0.34 from 4.1 nmol of LBSA/mg of protein. This marked cellular ganglioside depletion was confirmed by a metabolic radiolabeling study, in which we measured the inhibitory effect of D-PDMP on ganglioside synthesis. Following the treatment of LAN-5 cells with 10 µM D-PDMP for 72 h, ganglioside synthesis was already reduced by 90%, to 378 from 3495 dpm/mg of protein/h by the control cells.


Fig. 1. Effects of D-PDMP and retinoic acid on LAN-5 cellular gangliosides. LAN-5 cells were cultured in medium containing either 0.1% ethanol (control), 20 µM retinoic acid (RA), or 20 µM D-PDMP for 6 days. After the cells were harvested, the cellular gangliosides were quantified as nanomole of LBSA by the resorcinol assay (20). The data represent the mean and S.D. of three separate experiments.
[View Larger Version of this Image (36K GIF file)]



Fig. 2. Time course of the inhibitory effect of D-PDMP on cellular ganglioside content. LAN-5 cells were cultured in medium containing 10 µM D-PDMP for up to 6 days. At the indicated times, the cells were harvested and cellular gangliosides quantified as nanomole of LBSA by the resorcinol assay (20).
[View Larger Version of this Image (13K GIF file)]


Having found that retinoic acid treatment causes an increase in ganglioside content and that D-PDMP blocks ganglioside synthesis and causes a depletion of cellular gangliosides, it was important to establish the combined effect of these two agents on cellular gangliosides, since the subsequent experiments depended on blocked ganglioside synthesis and cellular ganglioside depletion in order to be able to test the role of endogenous ganglioside synthesis and content in differentiation. Therefore, we treated LAN-5 cells to maximally deplete cellular gangliosides. LAN-5 cells were first cultured in medium containing 20 µM D-PDMP for 6 days and then reseeded and cultured for an additional 6-day period under four different conditions, in medium containing 0.2% ethanol (control), 10 µM retinoic acid, 20 µM D-PDMP, or both 10 µM retinoic acid and 20 µM D-PDMP. As shown in Table I, LAN-5 cells treated with both retinoic acid and D-PDMP during the second 6-day period of culture had essentially the same cellular ganglioside content as did the cells treated with D-PDMP alone (0.54 versus 0.40 nmol of LBSA/mg of protein). Thus, the inhibitory effect of D-PDMP on ganglioside synthesis was dominant over the stimulatory effect of retinoic acid on ganglioside synthesis by LAN-5 human neuroblastoma cells. Under this condition, the two agents were not toxic to the cells, as evidenced by cell viability of >95%. Therefore, any effects on differentiation observed in the subsequent experiments would reflect a state of ganglioside depletion.

Table I.

Effects of retinoic acid and D-PDMP on neuroblastoma cellular gangliosides

LAN-5 cells were treated with 20 µM D-PDMP for 6 days and then were split into four flasks (T-75) in which these cells were further cultured in the medium containing 0.1% ethanol, 10 µM retinoic acid, 20 µM D-PDMP, or 10 µM retinoic acid + 20 µM D-PDMP for 6 days. Then the cells were harvested and the cellular gangliosides purified and quantified as nanomoles of LBSA by the resorcinol assay (20).
6-Day D-PDMP treatment followed by 6-day exposure to Ganglioside content
Nmol/flask Nmol/mg protein

0.1% Ethanol 6.24 3.21
10 µM Retinoic acid 3.89 3.76
20 µM D-PDMP 0.44 0.40
10 µM Retinoic acid + 20 µM D-PDMP 0.38 0.54

Differentiation of Retinoic Acid-treated LAN-5 Cells

We chose the human neuroblastoma cell line, LAN-5, which can be induced to differentiate by retinoic acid, as a model system to study whether depletion of cellular gangliosides prevents cellular differentiation. As previously shown (5, 21), LAN-5 human neuroblastoma cells propagated in the usual cell culture medium had large cell bodies and few, short processes (Fig. 3). The effect of retinoic acid treatment (10 µM for 6 days) was the induction of striking morphological changes, including rounding up of the cell body, extension of long processes with the appearance of neurites, and cell aggregation into tight clusters (6, 21). The cells still retained their long processes for at least 6 days after retinoic acid was removed (not shown). Biochemically, this neurite formation was accompanied by an increase in cellular ganglioside content, as discussed above.


Fig. 3. Effects of retinoic acid and D-PDMP on cellular differentiation of LAN-5 human neuroblastoma cells. LAN-5 cells were cultured for 6 days in medium containing either 0.2% ethanol (control), 10 µM retinoic acid, 20 µM D-PDMP, or 20 µM D-PDMP + 10 µM retinoic acid. Neurite formation indicates that the cells underwent retinoic acid-induced cellular differentiation. Magnification: × 400.
[View Larger Version of this Image (140K GIF file)]


D-PDMP, on the other hand, had no differentiating effect on LAN-5 cells, a finding consistent with a previous report that D-PDMP does not affect differentiation of HL-60 cells (22). Maximal exposure of LAN-5 human neuroblastoma cells to D-PDMP (20 µM for 6 days), which caused 92% reduction in cellular ganglioside content and had a growth inhibitory effect resulting in a lower cell density, did not cause any cell morphological changes in the cells compared to the control culture (Fig. 3). Specifically, the cells bodies remained spread out, the processes that were present were short, and despite the lower cell density, which resulted from the growth inhibitory effects of D-PDMP, the cells remained evenly distributed on the surface of the flask (i.e. not aggregated).

Study of the combined effects of D-PDMP and retinoic acid tested the necessity of endogenous gangliosides (inhibited by D-PDMP) for cellular differentiation (induced by retinoic acid). Surprisingly, LAN-5 cells cultured in medium containing both 10 µM retinoic acid and 20 µM D-PDMP for 6 days underwent exactly the same morphological changes (neurite formation, rounding up of the cell body, and cell aggregation into tight clusters) as did the cells treated with retinoic acid alone (Fig. 3). It should be emphasized that this neurite formation (Fig. 3) occurred despite the fact that D-PDMP had caused a state of almost completely blocked ganglioside synthesis and depleted cellular gangliosides (Figs. 1 and 2).

The observation of lack of inhibition by D-PDMP of induced cell differentiation was confirmed with a second experimental approach, even more prolonged exposure of LAN-5 cells to D-PDMP. In this experiment, LAN-5 cells were exposed to 20 µM D-PDMP for an initial 6-day period, and then reseeded and cultured for an additional 6-day period under the four different conditions used in the experiment shown in Table I (0.2% ethanol, 10 µM retinoic acid, 20 µM D-PDMP, or 10 µM retinoic acid and 20 µM D-PDMP). By the end of the initial 6-day culture period in D-PDMP alone, i.e. before the addition of retinoic acid, the cells were essentially depleted of gangliosides (Figs. 1 and 2). Exposed for 6 more days to D-PDMP as well as to retinoic acid, these cells once again demonstrated the neurite formation, rounding up, and aggregation associated with retinoic acid-induced cellular differentiation (Fig. 4). Therefore, the neurite formation of LAN-5 cells usually induced by retinoic acid was not blocked by D-PDMP, despite the depletion of cellular gangliosides caused by D-PDMP. L-threo-PDMP, an isomer of D-threo-PDMP, was also studied. It stimulated ganglioside synthesis, increasing cellular ganglioside content from 3.95 ± 0.39 to 5.06 ± 0.64 (n = 3) nmol of LBSA/mg of protein when the cells were exposed to 20 µM L-PDMP for 6 days, which is consistent with a previous report (23). However, it had no effect on neurite formation, nor did it inhibit retinoic acid-induced neurite formation (Fig. 5).


Fig. 4. Effect of prolonged D-PDMP treatment on neurite formation induced by retinoic acid in LAN-5 cells. LAN-5 cells were first exposed to 20 µM D-PDMP for 6 days and then reseeded and cultured in medium containing both 10 µM retinoic acid and 20 µM D-PDMP. Even after the extensive exposure of LAN-5 cells to D-PDMP to maximally deplete cellular gangliosides (see Table I) in this experiment, these cells still underwent cellular differentiation. Magnification: × 400.
[View Larger Version of this Image (130K GIF file)]



Fig. 5. Effects of L-PDMP on cellular differentiation of LAN-5 cells. LAN-5 cells were cultured for 6 days in medium containing (A) 0.2% ethanol, (B) 10 µM retinoic acid, (C) 20 µM L-PDMP, or (D) both 10 µM retinoic acid and 20 µM L-PDMP. Magnification: × 400.
[View Larger Version of this Image (183K GIF file)]


To further assess the influence of D-PDMP on the incidence and length of neurites, LAN-5 cells were seeded at a lower cell density (2 × 104 cells/cm2), and neurite response was quantified as described previously (5). The results (Table II) clearly showed the lack of influence of D-PDMP on the number and length of neurites induced by retinoic acid. In addition, LAN-5 cell differentiation was also assessed by measurement of acetylcholinesterase activity (17). Whereas retinoic acid caused a 2-fold increase in the acetylcholinesterase activity, consistent with previous studies (24), D-PDMP had only a minimal effect. The treatment of the cells with both D-PDMP and retinoic acid did not reduce the retinoic acid-induced increase in acetylcholinesterase activity (Table II). Together, these findings lead to the conclusion that induced differentiation of neuroblastoma cells does not require either intact endogenous ganglioside synthesis or content.

Table II.

Quantitative assessment of retinoic acid and D-PDMP effects on neurite response and acetylcholinesterase activity in LAN-5 human neuroblastoma cells

LAN-5 cells were cultured for 7 days in the medium containing 0.1% ethanol, 10 µM retinoic acid, 20 µM D-PDMP, or both 10 µM retinoic acid + 20 µM D-PDMP, and then harvested. Neurite response was assessed as previously described (5): cells were scored as morphologically differentiated if they possessed one or more processes at least twice as long as the soma diameter. Results were recorded as % differentiated cells in each culture: 4+ > 76%; 3+ = 51-75; 2+ = 26-50%; 1 < 25%. Acetylcholinesterase (AChE) activity was measured spectrophotometrically as described previously (17). The data are the mean ± S.D. of triplicate samples from a typical experiment.
Treatment Neurite response AChE activity

pmol/min/mg protein
0.1% Ethanol 1+ 14.3  ± 0.4
10 µM Retinoic acid 4+ 43.5  ± 1.3
20 µM D-PDMP 1+ 19.6  ± 0.5
10 µM Retinoic acid + 20 µM D-PDMP 4+ 65.8  ± 1.7

Stimulation of Neurite Formation in Nerve Growth Factor-treated LAN-5 Cells

We used NGF to induce neurite formation to provide an additional confirmation of these findings, since NGF-dependent trk A tyrosine phosphorylation followed by signal transduction leading to MAP kinase activation (25, 26) has been proposed to be an important mechanism for neuronal cell differentiation. NGF has already been shown to stimulate tyrosine phosphorylation of NGF receptor (p140prototrk) in LAN-5 cells (25). It seemed likely, therefore, that NGF should stimulate neurite formation in these LAN-5 cells. This was in fact the case; exposure of LAN-5 cells to 250-1000 ng/ml NGF for 8 days resulted in neurite formation. We next determined the effect of inhibition of endogenous ganglioside synthesis by D-PDMP on the NGF-mediated process. Just as in the case of retinoic acid-induced neurite formation, D-PDMP (20 µM, which completely inhibits ganglioside synthesis) did not block neurite formation stimulated by NGF (Fig. 6). These results support the conclusion that induced differentiation of neuroblastoma cells, whether by retinoic acid or by NGF, does not require either intact endogenous ganglioside synthesis or content.


Fig. 6. Effects of nerve growth factor and D-PDMP on neurite formation by LAN-5 cells. LAN-5 cells were cultured for 8 days in control (A) or in medium containing either (B) 1 µg/ml NGF, (C) 20 µM D-PDMP, or (D) both 1 µg/ml NGF and 20 µM D-PDMP. Magnification: × 400.
[View Larger Version of this Image (173K GIF file)]



DISCUSSION

There is great interest in the elucidation of biological functions of glycosphingolipids in general, and of gangliosides in particular. The involvement of gangliosides in neuronal cell differentiation of the nervous system is suggested by both qualitative and quantitative changes in ganglioside metabolism during brain development (27). Significant changes in human brain gangliosides have been observed in comparing the ganglioside complement of early fetal brain to that of adult brain (3). The ganglioside accretion is largest during the period of dendritic arborization and synaptogenesis (27). Developmental changes in ganglioside patterns were also observed in chick retina and brain (28) as well as in primary culture of rat neurons (29, 30, 31). Thus, ganglioside synthesis and expression have been considered to be an index of cellular differentiation in brain (32).

Striking changes in ganglioside synthesis have also been observed during cellular differentiation induced by certain pharmacological agents. Exposure of neuroblastoma cells to retinoic acid causes differentiation of the cells (5, 6) as well as a marked increase in cellular ganglioside content (7). More recent studies show that both induced and spontaneous neuritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane (8), where this ganglioside has been proposed to modulate nuclear calcium homeostasis during neurite outgrowth (12). An increase in concentration of specific gangliosides (8), the appearance of new gangliosides, and a switch in the ganglioside biosynthetic pathway have also been observed in other cell systems (9, 10). These changes in glycolipids were accompanied by the regulation of corresponding glycosyltransferases (33, 34, 35). Taken together, these studies clearly demonstrate that the process of cell differentiation, whether normal or pharmacologically induced, influences the biosynthesis of gangliosides.

The converse question is whether gangliosides influence the process of cell differentiation. Numerous studies have demonstrated that exogenous gangliosides are active. They stimulate axonal sprouting in vitro (36) and induce cellular differentiation with neurite formation in neuroblastoma cells (37, 38, 39, 40), although the mechanism is unknown. Another example is that very low concentrations (2-5 nM) of ganglioside GQ1b can induce neuroblastoma cells to differentiate (12). Human leukemia HL-60 cells can also be induced to differentiate, by incubation of the cells with exogenous ganglioside GM3 or sialylparagloboside (13, 14). A final example is that of ganglioside GM1, which enhanced neurite outgrowth elicited by nerve growth factor in two cell lines (41, 42).

Modulation of endogenous gangliosides has also been shown to influence the process of cellular differentiation. For example, treatment of neuroblastoma Neuro-2a cells with cholera toxin B-subunit and anti-GM1 antibody inhibited neurite outgrowth (43), and transfection of these same cells with a mammalian expression vector containing the cDNA encoding GD3 synthase caused the expression of GD3 synthase and changes in the cell morphology, consistent with cholinergic differentiation of neuroblastoma cells (44). Other investigators transfected F-11 neuroblastoma cells with the O-acetylesterase gene from influenza C virus (45). This altered the expression of GD3 and O-acetylated GD3, and caused morphological changes (45). Finally, treatment of HL-60 cells with GM2 and GD3 ganglioside synthase antisense oligomers resulted in alteration of ganglioside synthesis and composition and differentiation of the cells (11). On the other hand, inhibition of glycosphingolipid synthesis by D-PDMP did not affect fish embyo development (46).

The extensive studies reviewed above notwithstanding, the question of whether endogenous gangliosides are essential for cellular differentiation under physiological conditions remained to be resolved. This was the subject of the present investigation. We studied the influence of depletion of cellular gangliosides on cellular differentiation using D-PDMP, a competitive inhibitor of glucosylceramide synthase (15), which is the first enzyme for glycosphingolipid (and ganglioside) synthesis (16). If an intact ganglioside complement and/or ganglioside synthesis are critical for cellular differentiation induced by retinoic acid, the depletion of gangliosides should have prevented the neurite formation. To our surprise, blockade of ganglioside synthesis and depletion of cellular gangliosides had no discernable inhibitory effect on the formation of neurites induced by retinoic acid in human neuroblastoma LAN-5 cells. We confirmed this conclusion by showing that NGF-induced neurite formation (47) in LAN-5 cells likewise was not inhibited by blockade of ganglioside synthesis by D-PDMP.

The process of cellular differentiation includes (i) phenotypic changes of tumor cells associated with arrest of their proliferation, and (ii) phenotypic changes of normal cells in vitro, or most significantly in vivo, as part of maturation. Our studies have addressed the necessity of gangliosides in the former case, and have excluded the requirement of intact endogenous ganglioside metabolism and content for tumor cell differentiation. It will be very interesting now to address this same question in the context of normal cell differentiation, and particularly in vivo under physiological conditions, such as in a ganglioside knockout mouse.


FOOTNOTES

*   This work was supported in part by the Stewart Trust and Grants CA61010 and CA42361 from the National Cancer Institute. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Center for Cancer and Transplantation Biology, Children's Research Institute, 111 Michigan Ave., NW, Washington, D. C. 20010-2970. Tel.: 202-884-3898; Fax: 202-884-3929.
1    The abbreviations used are: D-PDMP, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol; LBSA, lipid-bound sialic acid; NGF, nerve growth factor.

REFERENCES

  1. Hakomori, S. (1990) J. Biol. Chem. 265, 18713-18716 [Abstract/Free Full Text]
  2. Moskal, J. R., Lockney, M. W., Marvel, C. C., Mason, P. A., and Sweeley, C. C. (1980) in Cell Surface Glycolipids (Sweeley, C. C., ed), pp. 241-263
  3. Svennerholm, L., Bostrom, K., Fredman, P., Mansson, J. E., Rosengren, B., and Rynmark, B. M. (1989) Biochim. Biophys. Acta. 1005, 109-117 [Medline] [Order article via Infotrieve]
  4. Dahms, N. M., and Schnaar, R. L. (1983) J. Neurosci. 3, 806-817 [Abstract]
  5. Sidell, N., Altman, A., Haussler, M. R., and Seeger, R. (1983) Exp. Cell Res. 148, 21-30 [Medline] [Order article via Infotrieve]
  6. Robson, J. A., and Sidell, N. (1985) Neuroscience 14, 1149-1162 [Medline] [Order article via Infotrieve]
  7. Li, R., and Ladisch, S. (1992) J. Neurochem. 59, 2297-2303 [Medline] [Order article via Infotrieve]
  8. Wu, G., Lu, Z.-H., and Ledeen, R. W. (1995) J. Neurosci. 15, 3739-3746 [Abstract]
  9. Kannagi, R., B., L. S., and Hakomori, S. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2844-2848 [Abstract]
  10. Fenderson, B. A., Andrews, P. W., Nudelman, E., Clausen, H., and Hakomori, S.-I. (1987) Dev. Biol 122, 21-34 [Medline] [Order article via Infotrieve]
  11. Zeng, G., Ariga, T., Gu, X.-b., and Yu, R. K. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8670-8674 [Abstract]
  12. Tsuji, S., Nakajima, J., Sasaki, T., Nagai, A., and Y. (1985) J. Biochem. 97, 969-972 [Abstract]
  13. Nojiri, H., Takaku, F., Terui, Y., Miura, Y., and Saito, M. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 782-786 [Abstract]
  14. Nojiri, H., Kitagawa, S., Nakamura, M., Kirito, K., Enomoto, Y., and Saito, M. (1988) J. Biol. Chem. 263, 7443-7446 [Abstract/Free Full Text]
  15. Inokuchi, J.-i., and Radin, N. S. (1987) J. Lipid Res. 28, 565-571 [Abstract]
  16. Radin, N. S., Shayman, J. A., and Inokuchi, J.-I. (1993) Adv. Lipid Res. 26, 183-213 [Medline] [Order article via Infotrieve]
  17. Ellman, G. L., Courtney, K. D., Andres, V., and Featherstone, R. M. (1961) Biochem. Pharmacol. 7, 88-95 [CrossRef][Medline] [Order article via Infotrieve]
  18. Li, R., and Ladisch, S. (1991) Biochim. Biophys. Acta 1083, 57-64 [Medline] [Order article via Infotrieve]
  19. Ladisch, S., and Gillard, B. (1985) Anal. Biochem. 146, 220-231 [Medline] [Order article via Infotrieve]
  20. Ledeen, R., and Yu, R. (1982) Methods Enzymol. 83, 139-191 [Medline] [Order article via Infotrieve]
  21. Sidell, N., Worth, G. D., and Seeger, R. C. (1983) Modulation and Mediation of Cancer by Vitamins, pp. 228-235, Karger, Basel
  22. Kan, C.-C., and Kolesnick, R. N. (1992) J. Biol. Chem. 267, 9663-9667 [Abstract/Free Full Text]
  23. Inokuchi, J.-i., Usuki, S., and Jimbo, M. (1995) J. Biochem. (Tokyo) 117, 766-773 [Abstract]
  24. Han, G., Chang, B., Connor, M. J., and Sidell, N. (1995) Differentiation 59, 61-69 [CrossRef][Medline] [Order article via Infotrieve]
  25. Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., and Parada, L. F. (1991) Science 252, 554-558 [Medline] [Order article via Infotrieve]
  26. Klein, R., Jing, S., Nanduri, V., O'Rouke, E., and Barbacid, M. (1991) Cell 65, 189-197 [Medline] [Order article via Infotrieve]
  27. Ledeen, R. W. (1984) J. Neurosci. Res. 12, 147-159 [Medline] [Order article via Infotrieve]
  28. Dreyfus, H., Urban, P. F., Edel-Harth, S., and Mandel, P. (1975) J. Neurochem. 25, 245-250 [Medline] [Order article via Infotrieve]
  29. Dreyfus, H., Louis, J. C., Harth, S., and Mandel, P. (1980) Neuroscience 5, 1647-1655 [Medline] [Order article via Infotrieve]
  30. Irwin, L. N., and Irwin, C. C. (1979) Dev. Neurosci. 2, 129-138
  31. Ogiso, M., Ohta, M., Harana, Y., Kubos, H., and Hirano, S. (1991) Neuroscience 41, 167-176 [Medline] [Order article via Infotrieve]
  32. Tettamanti, G., and Riboni, L. (1994) in Progress in Brain Research (Svennerholm, L., Asbury, A., Reisfeld, R., Sandhoff, K., Suzuki, K., Tettamanti, G., and Toffano, G., eds), Vol. 101, pp. 77-100, Elsevier, Amsterdam
  33. Moskal, J. R., Lockney, M. W., Marvel, C. C., Trosko, J. E., and Sweeley, C. C. (1987) Cancer Res. 47, 787-790 [Abstract]
  34. Chen, C., Fenderson, B. A., Andrews, P. W., and Hakomori, S. (1989) Biochemistry 28, 2229-2238 [Medline] [Order article via Infotrieve]
  35. Walton, K. M., and Schnaar, R. L. (1989) J. Neurochem. 52, 1537-1544 [Medline] [Order article via Infotrieve]
  36. Roisen, F. J., Bartfeld, H., Nagele, R., and Yorke, G. (1981) Science 214, 577-578 [Medline] [Order article via Infotrieve]
  37. Leon, A., Facci, L., Benvegnu, D., and Toffano, G. (1982) Dev. Neurosci. 5, 108-114 [Medline] [Order article via Infotrieve]
  38. Facci, L., Leon, A., Toffano, G., Sonnino, S., Ghidoni, R., and Tettamanti, G. (1984) J. Neurochem. 42, 299-305 [Medline] [Order article via Infotrieve]
  39. Wu, G., Vaswani, K. K., Lu, Z.-H., and Ledeen, R. W. (1990) J. Neurochem. 55, 484-491 [Medline] [Order article via Infotrieve]
  40. Nagai, Y. (1995) Behav. Brain Res. 66, 99-104 [CrossRef][Medline] [Order article via Infotrieve]
  41. Mutoh, T., Tokuda, A., Miyadai, T., Hamaguchi, M., and Fujiki, N. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5087-5091 [Abstract]
  42. Rabin, S. J., and Mocchetti, I. (1995) J. Neurochem. 65, 347-354 [Medline] [Order article via Infotrieve]
  43. Wu, G., Nakamura, K., and Ledeen, R. W. (1994) Mol. Chem. Neuropathol. 21, 259-271 [Medline] [Order article via Infotrieve]
  44. Kojima, N., Kurosawa, N., Nishi, T., Hanai, N., and Tsuji, S. (1994) J. Biol. Chem. 269, 30451-30456 [Abstract/Free Full Text]
  45. Ariga, T., Blaine, G. M., Yoshino, H., Dawson, G., Kanda, T., Zeng, G. C., Kasama, T., Kushi, Y., and Yu, R. K. (1995) Biochemistry 34, 11500-11507 [Medline] [Order article via Infotrieve]
  46. Fenderson, B. A., Ostrander, G. K., Hausken, Z., Radin, N. S., and Hakomori, S.-i. (1992) Exp. Cell Res. 198, 362-366 [Medline] [Order article via Infotrieve]
  47. Campbell, X. Z., and Neet, K. E. (1995) J. Neurosci. Res. 42, 207-219 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.